ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Paediatrics · Lancet Child Adolesc Health · 2026-03-16

In 269 children aged 1-10 with first steroid-sensitive nephrotic syndrome, mycophenolate mofetil was non-inferior to prednisone for treated relapse over 24 months (79.1% vs 74.8%), with less hypertension and psychological problems but more infections (69.9% vs 55.6%).

RCTn = 272
Benz et al. Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.